PTC Therapeutics Inc’s filing revealed that its CHIEF BUSINESS OFFICER Pauwels Eric unloaded Company’s shares for reported $2.27 million on Sep 08 ’25. In the deal valued at $56.92 per share,39,850 shares were sold. As a result of this transaction, Pauwels Eric now holds 72,912 shares worth roughly $4.26 million.
Then, SOUTHWELL DAVID P bought 12,000 shares, generating $700,129 in total proceeds.
Before that, Pauwels Eric bought 39,850 shares. PTC Therapeutics Inc shares valued at $2,268,374 were divested by the Officer at a price of $56.92 per share.
Truist initiated its PTC Therapeutics Inc [PTCT] rating to a Buy in a research note published on June 17, 2025; the price target was $80. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early May from “a Neutral” to “a Buy”. Citigroup also remained covering PTCT and has increased its forecast on May 07, 2025 with a “Neutral” recommendation from previously “Sell” rating. BofA Securities revised its rating on March 11, 2025. It rated PTCT as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of PTCT
On Tuesday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 2.58% to $58.42. Over the last five days, the stock has gained 11.42%. PTC Therapeutics Inc shares have risen nearly 84.87% since the year began. Nevertheless, the stocks have risen 29.42% over the past one year. While a 52-week high of $58.73 was reached on 09/05/25, a 52-week low of $30.98 was recorded on 05/06/25.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 57.36, which if violated will result in even more drops to 56.30. On the upside, there is a resistance level at 59.07. A further resistance level may holdings at 59.72.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2025-08-15, growing by 0.72 million shares to a total of 6.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 5.77 million shares. There was a rise of 11.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 07, 2025 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $55 price target.
